Peter Daly

The Group's principal activity is discovering and developing novel therapeutics for the treatment of cancer. It focuses on the study of cancer cell survival and growth, with a research base encompassing apoptosis biology, cancer biomarkers and the metabolic basis of drug resistance in tumours. The Group creates intellectual property that seeks to exploit through in-house product development and licensing.

Part of UniPhar Group Ltd., Cahill May Roberts Ltd. is a pharmaceutical product distributor. The company is based in Chapelizod, Ireland. Cahill May Roberts was acquired by UniPhar Group Ltd. from McKesson Europe AG on April 30, 2013 for $63.43 million.

NeuroCure Ltd. manufactures drugs to cure psychiatric and central nervous system diseases. It has programs available for out-licensing and its licensing novel use inventions supported by clinical data and with novel formulations. The company was founded by Ted Dinan and Peter Daly in 2003 and is headquartered in Dublin, Ireland.